Cover
Cover | Jan. 07, 2022 |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Jan. 7, 2022 |
Entity File Number | 001-39871 |
Entity Registrant Name | SAB Biotherapeutics, Inc. |
Entity Central Index Key | 0001833214 |
Entity Tax Identification Number | 85-3899721 |
Entity Incorporation, State or Country Code | DE |
Entity Address, Address Line One | 2100 East 54th Street North |
Entity Address, City or Town | Sioux Falls |
Entity Address, State or Province | SD |
Entity Address, Postal Zip Code | 57104 |
City Area Code | (605) |
Local Phone Number | 679-6980 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Entity Emerging Growth Company | true |
Elected Not To Use the Extended Transition Period | false |
Entity Information, Former Legal or Registered Name | Not Applicable |
Common Stock, $0.0001 par value per share | |
Title of 12(b) Security | Common Stock, $0.0001 par value per share |
Trading Symbol | SABS |
Security Exchange Name | NASDAQ |
Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share | |
Title of 12(b) Security | Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share |
Trading Symbol | SABSW |
Security Exchange Name | NASDAQ |